{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:27:57Z","timestamp":1777390077010,"version":"3.51.4"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Hypertension, a significant risk factor for cardiovascular diseases, demands proactive management as cardiovascular diseases remain the leading cause of death worldwide. Reducing systolic and diastolic blood pressure levels below recommended reference values of &amp;lt;140\/90\u00a0mmHg can lead to a significant reduction of the risk of CVD and all-cause mortality. However, treatment of hypertension can be difficult and the presence of comorbidities could further complicate this treatment. Drugs used to manage these comorbidities may inadvertently have an impact on blood pressure, resulting in a phenomenon known as drug-disease interaction. This study aims to assess the safety of medication that can affect blood pressure in patients with hypertension and provide practical recommendations for healthcare professionals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>For the development of recommendations for the drug-disease interaction (DDSI) hypertension, a six-step plan that combined literature selection and multidisciplinary expert opinion was used. The process involved (1) defining the scope of the DDSI and selecting relevant drugs, (2) collecting evidence, (3) data-extraction, (4) reaching of expert consensus, (5) publication and implementation of the recommendations in healthcare systems and (6) updating the information.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>An increase of 10\u00a0mmHg in systolic blood pressure and 5\u00a0mmHg in diastolic blood pressure was defined as clinically relevant. Corticosteroids, danazol, and yohimbine caused a clinically relevant DDSI with hypertension. Several other drugs with warnings for hypertension in the official product information were assessed to have no clinically relevant DDSI due to minor influence or lack of data on blood pressure. Drugs with evidence for a relevant change in blood pressure which are prescribed under close monitoring of blood pressure according to clinical guidelines, were deemed to be not clinically relevant for signalling.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>This study provides specific recommendations that can be implemented directly in clinical practice, for example, in clinical decision support systems, potentially resulting in safer drug use in patients with hypertension and better healthcare by reducing alert fatigue. Future research should focus on evaluating the effectiveness of implementation strategies and their impact on reducing unsafe use of medication in patients with hypertension.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1360146","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T04:57:53Z","timestamp":1713329873000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Developing practical recommendations for drug-disease interactions in patients with hypertension"],"prefix":"10.3389","volume":"15","author":[{"given":"K\u00fcbra","family":"\u00d6zokcu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike M. E.","family":"Diesveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzan G. H.","family":"Gipmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E. J.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert-Jan","family":"van den Born","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sander D.","family":"Borgsteede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/AOG.0000000000003072","article-title":"No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions","volume":"133","year":"2019","journal-title":"Obstetrics and Gynecology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/RHU.0000000000000736","article-title":"Initiation of disease-modifying therapies in rheumatoid arthritis is associated with changes in blood pressure","volume":"24","author":"Baker","year":"2018","journal-title":"JCR J. Clin. Rheumatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/1471-0528.13352","article-title":"Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey","volume":"122","author":"Bernard","year":"2015","journal-title":"BJOG"},{"key":"B4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12931-018-0742-y","article-title":"Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis","volume":"19","author":"Bloechliger","year":"2018","journal-title":"Respir. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1527-3458.2003.tb00245.x","article-title":"Moclobemide: therapeutic use and clinical studies","volume":"9","author":"Bonnet","year":"2003","journal-title":"CNS Drug Rev."},{"key":"B7","article-title":"Commentaren medicatiebewaking","author":"Borgsteede","year":"2023","journal-title":"Health Base Found"},{"key":"B8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3122\/jabfm.2018.01.170234","article-title":"Antidepressants and incident hypertension in primary care patients","volume":"31","author":"Breeden","year":"2018","journal-title":"J. Am. Board Fam. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/archinte.140.10.1379","article-title":"Hypertension: a complication of danazol therapy","volume":"140","author":"Bretza","year":"1980","journal-title":"Arch. Intern Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol."},{"key":"B11","volume-title":"About multiple cause of death, 1999\u20132020","year":"2022"},{"key":"B12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/EDE.0000000000000840","article-title":"Depressive symptoms, antidepressant use, and hypertension in young adulthood","volume":"29","author":"Crookes","year":"2018","journal-title":"Epidemiology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF00315481","article-title":"The effect of yohimbine on sympathetic responsiveness in essential hypertension","volume":"44","author":"Damase-Michel","year":"1993","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s11096-021-01308-0","article-title":"Management of drug-disease interactions: a best practice from The Netherlands","volume":"43","author":"Diesveld","year":"2021","journal-title":"Int. J. Clin. Pharm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2190\/PM.47.2.c","article-title":"Outcome of treatment with antidepressants in patients with hypertension and undetected depression","volume":"47","author":"Diminic-Lisica","year":"2014","journal-title":"Int. J. Psychiatry Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"303s","DOI":"10.1042\/cs057303s","article-title":"Studies on the mechanism of mineralocorticoid-induced blood pressure increase in man","volume":"57","author":"Distler","year":"1979","journal-title":"Clin. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.18549\/PharmPract.2021.1.2248","article-title":"Primary healthcare policy and vision for community pharmacy and pharmacists in Germany","volume":"19","author":"Eickhoff","year":"2021","journal-title":"Pharm. Pract. (Granada)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"B19","volume-title":"A guideline on Summary of Product Characteristics (SmPC)","year":"2009"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1210\/jc.2015-1127","article-title":"Synthetic glucocorticoids and early variations of blood pressure: a population-based cohort study","volume":"100","author":"Fardet","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJMoa1803180","article-title":"Effect of systolic and diastolic blood pressure on cardiovascular outcomes","volume":"381","author":"Flint","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.jocn.2015.03.067","article-title":"Antidepressant medication can improve hypertension in elderly patients with depression","volume":"22","author":"Fu","year":"2015","journal-title":"J. Clin. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/00005344-199307000-00004","article-title":"Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients","volume":"22","author":"Grossman","year":"1993","journal-title":"J. Cardiovasc Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3109\/0886022X.2012.672313","article-title":"Hyperprolactinemia as a rare cause of hypertension in chronic renal failure","volume":"34","author":"Gulleroglu","year":"2012","journal-title":"Ren. Fail"},{"key":"B25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF01872390","article-title":"Bromocriptine and suppression of postpartum lactation. The incidence of adverse cardiovascular effects in women of child-bearing age","volume":"17","author":"Herings","year":"1995","journal-title":"Pharm. World and Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/ndt\/gfg515","article-title":"Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities","volume":"19","author":"Higgins","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"B27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.33549\/physiolres.933332","article-title":"Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension","volume":"66","author":"Ho\u0161kov\u00e1","year":"2017","journal-title":"Physiological Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/archinternmed.2008.551","article-title":"Overrides of medication alerts in ambulatory care","volume":"169","author":"Isaac","year":"2009","journal-title":"Arch. Intern Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/00004714-198902000-00011","article-title":"Autoinduction of hypertensive reactions by tranylcypromine?","volume":"9","author":"Keck","year":"1989","journal-title":"J. Clin. Psychopharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s002340000492","article-title":"The role of hypertension in bromocriptine-related puerperal intracranial hemorrhage","volume":"43","author":"Kirsch","year":"2001","journal-title":"Neuroradiology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/00007890-200203150-00012","article-title":"Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects","volume":"73","author":"Klein","year":"2002","journal-title":"Transplantation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0006-3223(93)90384-p","article-title":"Spontaneous hypertensive reactions with monoamine oxidase inhibitors","volume":"34","author":"Lavin","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.108.126698","article-title":"Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension","volume":"53","author":"Licht","year":"2009","journal-title":"Hypertension"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension: endorsed by the international society of hypertension (ISH) and the European renal association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J. Hypertens."},{"key":"B36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.vph.2018.06.012","article-title":"Treatment of cyclosporine induced hypertension: results from a long-term observational study using different antihypertensive medications","volume":"115","author":"Marienhagen","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10157-015-1139-6","article-title":"Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome","volume":"20","author":"Miyabe","year":"2016","journal-title":"Clin. Exp. Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0895-7061(95)00037-P","article-title":"Yohimbine effects on blood pressure and plasma catecholamines in human hypertension","volume":"8","author":"Musso","year":"1995","journal-title":"Am. J. Hypertens."},{"key":"B39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/amiajnl-2013-001813","article-title":"Overrides of medication-related clinical decision support alerts in outpatients","volume":"21","author":"Nanji","year":"2014","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B40","doi-asserted-by":"crossref","first-page":"146045822110075","DOI":"10.1177\/14604582211007536","article-title":"The appropriateness of clinical decision support systems alerts in supporting clinical workflows: a systematic review","volume":"27","author":"Olakotan","year":"2021","journal-title":"Health Inf. J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/rheumatology\/kem311","article-title":"Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis","volume":"47","author":"Panoulas","year":"2008","journal-title":"Rheumatology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/003693309003500207","article-title":"Benign intracranial hypertension associated with danazol","volume":"35","author":"Pears","year":"1990","journal-title":"Scott Med. J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/10641963.2018.1501058","article-title":"Effects of SSRI medication on heart rate and blood pressure in individuals with hypertension and depression","volume":"41","author":"Peixoto","year":"2019","journal-title":"Clin. Exp. Hypertens."},{"key":"B44","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/amiajnl-2012-001089","article-title":"Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records","volume":"20","author":"Phansalkar","year":"2013","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/2008-7802.174891","article-title":"Can antidepressant drug impact on blood pressure level in patients with psychiatric disorder and hypertension? A randomized trial","volume":"7","author":"Razavi Ratki","year":"2016","journal-title":"Int. J. Prev. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1080\/03007995.2018.1474090","article-title":"Quantitative characterization of the relationship between levels of extended corticosteroid use and related adverse events in a US population","volume":"34","author":"Rice","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"key":"B48","doi-asserted-by":"publisher","first-page":"CD007893","DOI":"10.1002\/14651858.CD007893.pub2","article-title":"Effect of cyclosporine on blood pressure","author":"Robert","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"B49","volume-title":"Medicines information centre. Contra-Indicatie aandoeningen","year":"2023"},{"key":"B50","first-page":"237","article-title":"Lifestyle modifications to prevent and control hypertension","volume":"10","author":"Samadian","year":"2016","journal-title":"Iran. J. Kidney Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1177\/0961203311411347","article-title":"Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients","volume":"20","author":"Sazliyana","year":"2011","journal-title":"Lupus."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/jamia\/ocaa222","article-title":"Renal medication-related clinical decision support (CDS) alerts and overrides in the inpatient setting following implementation of a commercial electronic health record: implications for designing more effective alerts","volume":"28","author":"Shah","year":"2021","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1001\/jama.2020.11935","article-title":"Hormonal contraception in women with hypertension","volume":"324","author":"Shufelt","year":"2020","journal-title":"JAMA"},{"key":"B54","doi-asserted-by":"publisher","first-page":"83S","DOI":"10.1016\/j.transproceed.2004.01.089","article-title":"Single-Center experience with cyclosporine therapy for kidney transplantation: analysis of a Twenty-Year period in 1200 patients","volume":"36","author":"Snanoudj","year":"2004","journal-title":"Transpl. Proc."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jamapediatrics.2019.3310","article-title":"Global prevalence of hypertension in children: a systematic review and meta-analysis","volume":"173","author":"Song","year":"2019","journal-title":"JAMA Pediatr."},{"key":"B56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/svn-2017-000138","article-title":"Controlling resistant hypertension","volume":"3","author":"Spence","year":"2018","journal-title":"Stroke Vasc. Neurol."},{"key":"B57","article-title":"Essential psychopharmacology","volume-title":"Neuroscientific basis and practical applications","author":"Stahl","year":"2013"},{"key":"B58","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1017\/s1092852900016965","article-title":"Monoamine oxidase inhibitors: a modern Guide to an unrequited Class of antidepressants","volume":"13","author":"Stahl","year":"2008","journal-title":"CNS Spectr."},{"key":"B59","doi-asserted-by":"publisher","first-page":"657","DOI":"10.4088\/jcp.v66n0519e","article-title":"Do antihypertensives make tranylcypromine safer?","volume":"66","author":"Taylor","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"B60","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/s1053-2498(98)00060-6","article-title":"A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus","volume":"18","author":"Taylor","year":"1999","journal-title":"J. Heart Lung Transplant."},{"key":"B61","doi-asserted-by":"publisher","first-page":"502","DOI":"10.4088\/jcp.v59n1002","article-title":"Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients","volume":"59","author":"Thase","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"B62","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1197\/jamia.M1809","article-title":"Overriding of drug safety alerts in computerized physician order entry","volume":"13","author":"van der Sijs","year":"2006","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2165\/00002018-200528120-00007","article-title":"Clinical relevance of drug-drug interactions: a structured assessment procedure","volume":"28","author":"van Roon","year":"2005","journal-title":"Drug Saf."},{"key":"B64","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3389\/fphar.2020.00707","article-title":"The development of practice recommendations for drug-disease interactions by literature review and expert opinion","volume":"11","author":"van Tongeren","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1161\/HYPERTENSIONAHA.112.201400","article-title":"Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project","volume":"60","author":"Vishram","year":"2012","journal-title":"Hypertension"},{"key":"B66","unstructured":"Ziekten van hart en vaatstelsel Sterftecijfers2022"},{"key":"B67","first-page":"573","article-title":"Bromocriptine mesylate for lactation suppression: a risk for postpartum hypertension?","volume":"74","author":"Watson","year":"1989","journal-title":"Obstetrics Gynecol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3389\/fphar.2019.01031","article-title":"Evaluation of information in summaries of product characteristics (SmPCs) on the use of a medicine in patients with hepatic impairment","volume":"10","author":"Weersink","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11096-017-0450-6","article-title":"Interprofessional communication between community pharmacists and general practitioners: a qualitative study","volume":"39","author":"Weissenborn","year":"2017","journal-title":"Int. J. Clin. Pharm."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/HYP.0000000000000065","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2017","journal-title":"Hypertension"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.jacc.2022.07.005","article-title":"Harmonization of the American College of Cardiology\/American heart association and European society of Cardiology\/European society of hypertension blood pressure\/hypertension guidelines: comparisons, reflections, and recommendations","volume":"80","author":"Whelton","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/08037051.2018.1527177","article-title":"2018 practice guidelines for the management of arterial hypertension of the European society of Cardiology and the European society of hypertension","volume":"27","author":"Williams","year":"2018","journal-title":"Blood Press"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/sj.bmt.1701027","article-title":"Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation","volume":"20","author":"Woo","year":"1997","journal-title":"Bone Marrow Transpl."},{"key":"B74","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0161-813X(03)00097-4","article-title":"Clinical pharmacology of MAO inhibitors: safety and future","volume":"25","author":"Yamada","year":"2004","journal-title":"Neurotoxicology"},{"key":"B75","first-page":"366","article-title":"Hypertension en orthostatic hypotension during use of monoamine oxidase (MAO) inhibitors","volume":"59","author":"Zandee","year":"2017","journal-title":"Tijdschr. Psychiatr."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1360146\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T04:58:07Z","timestamp":1713329887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1360146\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":74,"alternative-id":["10.3389\/fphar.2024.1360146"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1360146","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"article-number":"1360146"}}